Advertisement

Price discrimination in the Italian medical device industry: an empirical analysis

  • G. CreaEmail author
  • A. Cavaliere
  • A. Cozzi
Original Paper
  • 12 Downloads

Abstract

In this paper we ascertain that the Italian market for medical devices is characterized by significant price dispersion. We have, therefore, carried out an econometric analysis, as well as a Bayesian network analysis to verify if price dispersion is due to price discrimination. We have found that ASLs (Aziende Sanitarie Locali) incur higher procurement costs than AOs (Aziende Ospedaliere), which purchase larger quantities as Centralized purchasing agencies do. Consequently, second-degree price discrimination may be one of the causes of price differences. Price levels are also inversely related to product age because of intense innovative activity, making product differentiation more likely than price discrimination. Public procurement agents located in Southern Italy pay higher prices than those located in Northern or Central Italy. This is due to the higher probability for Southern procurement agents to purchase from independent wholesalers, rather than from producers, implying a double marginalization effect which raises final prices. It is also more likely that obsolete medical devices are sold to Southern health care providers.

Keywords

Price dispersion Bayesian networks Double marginalization 

JEL Classification

I11 H51 L11 

Notes

References

  1. Assobiomedica (2010). La posizione associativa in tema di prezzi dei dispositivi medici: Attenzione ai confronti impropri. http://www.assobiomedica.it/static/upload/pp_/pp__prezzidispositivi-03.pdf. Accessed Dec 2017.
  2. Bonaccorsi, A., Lyon, T. P., Pammolli, F., & Turchetti, G. (2000). Auctions vs. bargaining: An empirical analysis of medical device procurement. LEM Working Paper Series. 1999/20.Google Scholar
  3. Boscolo, P. R., & Tarricone, R. (2013). La rilevanza economica e sociale del mercato dei dispositivi medici. caratteristiche distintive del prodotto, delle imprese produttrici e delle relazioni con il settore pubblico. Aidea 2013 Conference Papers.Google Scholar
  4. Burns, L. R., & Lee, J. A. (2008). Hospital purchasing alliances: Utilization, services, and performance. Health Care Management Review, 33(3), 203–215.CrossRefGoogle Scholar
  5. Centro Studi Assobiomedica (2012a). I tempi medi di pagamento delle strutture sanitarie pubbliche. Studi n.24. https://www.assobiomedica.it/it/pubblicazioni/index.html. Accessed Dec 2017.
  6. Centro Studi Assobiomedica (2012b). Produzione, ricerca e innovazione nel settore dei dispositivi medici in Italia. Rapporto. https://www.assobiomedica.it/it/pubblicazioni/index.html. Accessed Dec 2017.
  7. Centro Studi Assobiomedica (2013). I tempi medi di pagamento delle strutture sanitarie pubbliche. Studi n.25. https://www.assobiomedica.it/it/pubblicazioni/index.html. Accessed Dec 2017.
  8. Centro Studi Assobiomedica (2014). Average payment times of public and private health-care organisations. Studies n.28. https://www.assobiomedica.it/it/pubblicazioni/index.html. Accessed Dec 2017.
  9. Centro Studi Assobiomedica (2015a). I tempi medi di pagamento delle strutture sanitarie pubbliche e private. Studi n.31. https://www.assobiomedica.it/it/pubblicazioni/index.html. Accessed Dec 2017.
  10. Centro Studi Assobiomedica (2015b). Le politiche pubbliche d’acquisto di dispositivi medici. Studi n.30. https://www.assobiomedica.it/it/pubblicazioni/index.html. Accessed Dec 2017.
  11. Centro Studi Assobiomedica (2016). Le politiche pubbliche d’acquisto di dispositivi medici, secondo aggiornameto. Studi n.33. https://www.assobiomedica.it/it/pubblicazioni/index.html. Accessed Dec 2017.
  12. Dimitri, N., Dini, F., & Piga, G. (2006). When should procurement be centralized? Handbook of procurement, 47–81. Cambridge: Cambridge University Press.Google Scholar
  13. Eucomed (2014a). The European medical technology industry in figures. http://www.eucomed.be/uploads/Modules/Publications/20141003-medtech-brochure-digital-1.pdf. Accessed Dec 2017.
  14. Eucomed (2014b). Key principles of smart procurement for medical devices. http://www.medtecheurope.org/uploads/Modules/Publications/20141020_eucomed-key-principles-of-smart-procurement-for-medical-devices-final.pdf. Accessed Dec 2017.
  15. European Council Directive 93/42/EEC of June 14 (1993).Google Scholar
  16. Ferré, F., de Belvis, A. G., Valerio, L., Longhi, S., Lazzari, A., Fattore, G., Ricciardi, W., & Maresso, A. (2014). Italy: Health system review. European Observatory on Health Systems and Policies. http://www.who.int/iris/handle/10665/141626.
  17. Grennan, M. (2013). Price discrimination and bargaining: Empirical evidence from medical devices. American Economic Review, 103(1), 145–177.CrossRefGoogle Scholar
  18. Hahn, R. W., Klovers, K. B., & Singer, H. J. (2008). The need for greater price transparency in the medical device industry: An economic analysis. Health Affairs, 27(6), 1554–1559.CrossRefGoogle Scholar
  19. Italian Legislative Decree n. 46 of February 24 (1997). Attuazione della direttiva 93/42/CEE concernente i dispositivi medici. Gazzetta Ufficiale della Repubblica Italiana n. 54 del 6 marzo 1997.Google Scholar
  20. Lerner, J. C., Fox, D. M., Nelson, T., & Reiss, J. B. (2008). The consequence of secret prices: The politics of physician preference items. Health Affairs, 27(6), 1560–1565.CrossRefGoogle Scholar
  21. Medtech Europe (2018). The European Medical Technology industry in figures. http://www.medtecheurope.org/sites/default/files/resource_items/files/MedTech%20Europe_FactsFigures2018_FINAL_1.pdf. Accessed Apr 2018.
  22. Ministero della Salute (2014). Rapporto sulla spesa rilevata dalle strutture sanitarie pubbliche del SSN per l’acquisto di dispositivi medici - anno 2013. http://www.salute.gov.it/imgs/C_17_pubblicazioni_2259_allegato.pdf. Accessed Dec 2017.
  23. Neapolitan, R. E. (2004). Learning Bayesian Networks (Vol. 38). Upper Saddle River: Prentice Hall.Google Scholar
  24. Nielsen, T. D., & Jensen, F. V. (2009). Bayesian Networks and Decision Graphs. New York: Springer.Google Scholar
  25. Novi, D., & Rizzi, Z. (2017). Scale effects and expected savings from consolidation policies of Italian local healthcare authorities. Applied Health Economics and Health Policy., 16(1), 107–122.CrossRefGoogle Scholar
  26. Pammolli, F., Riccaboni, M., Oglialoro, C., Magazzini, L., Baio, G., & Salerno, N. (2005). Medical devices competitiveness and impact on public health expenditure. Brussels: Enterprise Directorate-General, European Commission.Google Scholar
  27. Pauly, M. V., & Burns, L. R. (2008). Price transparency for medical devices. Health Affairs, 27(6), 1544–1553.CrossRefGoogle Scholar
  28. Sorenson, C., & Kanavos, P. (2011). Medical technology procurement in Europe: A cross-country comparison of current practice and policy. Health Policy, 100(1), 43–50.CrossRefGoogle Scholar
  29. Stigler, G. (1987). Theory of price. New York: Macmillan.Google Scholar
  30. Stole, L. A. (2007). Price discrimination and competition. Handbook of Industrial Organization, 3, 2221–2299.CrossRefGoogle Scholar
  31. Tirole, J. (1988). The Theory of Industrial Organization. Cambridge: MIT Press.Google Scholar
  32. Varian, H. R. (1989). Price discrimination. Handbook of Industrial Organization, 1, 597–654.CrossRefGoogle Scholar
  33. Vellez, M. (2011). Auctions versus negotiations: Evidence from public procurement in the Italian healthcare sector. CEIS Working Papers. N 191.Google Scholar
  34. Vellez, M. (2012). Determinants of price discrimination in the acquisition of medical devices. CEIS Working Papers. 235. Google Scholar
  35. Wooldridge, J. (2009). Introductory econometrics: A modern approach (4th ed.). Boston: Cengage Learning.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Dipartimento di Scienze Economiche e AziendaliUniversità di PaviaPaviaItaly

Personalised recommendations